255 related articles for article (PubMed ID: 32851744)
21. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
22. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
[TBL] [Abstract][Full Text] [Related]
23. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
24. A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in Women With Female Pattern Hair Loss.
Bergfeld W; Washenik K; Callender V; Zhang P; Quiza C; Doshi U; Blume-Peytavi U
J Drugs Dermatol; 2016 Jul; 15(7):874-81. PubMed ID: 27391639
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study.
Hossein Mostafa D; Samadi A; Niknam S; Nasrollahi SA; Guishard A; Firooz A
J Pharm Pharm Sci; 2021; 24():191-199. PubMed ID: 33909554
[TBL] [Abstract][Full Text] [Related]
26. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
[TBL] [Abstract][Full Text] [Related]
27. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
Suchonwanit P; Rojhirunsakool S; Khunkhet S
Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Minoxidil Combined With Photobiomodulation for the Treatment of Male Androgenetic Alopecia. A Double-Blind Half-Head Controlled Trial.
Ferrara F; Kakizaki P; de Brito FF; Contin LA; Machado CJ; Donati A
Lasers Surg Med; 2021 Nov; 53(9):1201-1207. PubMed ID: 33998004
[TBL] [Abstract][Full Text] [Related]
29. Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men: a 104-week open-label clinical trial.
Kanti V; Hillmann K; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1183-9. PubMed ID: 26387973
[TBL] [Abstract][Full Text] [Related]
30. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
31. The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia.
Faghihi G; Mozafarpoor S; Asilian A; Mokhtari F; Esfahani AA; Bafandeh B; Nouraei S; Nilforoushzadeh MA; Hosseini SM
Indian J Dermatol Venereol Leprol; 2018; 84(5):547-553. PubMed ID: 30027912
[TBL] [Abstract][Full Text] [Related]
32. Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
Gupta AK; Venkataraman M; Talukder M; Bamimore MA
JAMA Dermatol; 2022 Mar; 158(3):266-274. PubMed ID: 35107565
[TBL] [Abstract][Full Text] [Related]
33. Topical adenosine increases thick hair ratio in Japanese men with androgenetic alopecia.
Watanabe Y; Nagashima T; Hanzawa N; Ishino A; Nakazawa Y; Ogo M; Iwabuchi T; Tajima M
Int J Cosmet Sci; 2015 Dec; 37(6):579-87. PubMed ID: 25925959
[TBL] [Abstract][Full Text] [Related]
34. Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination with Immunohistochemical Study of the Dynamics of Cell Proliferation in the Treatment of Men with Androgenetic Alopecia.
Pakhomova EE; Smirnova IO
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899959
[TBL] [Abstract][Full Text] [Related]
35. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial.
Panahi Y; Taghizadeh M; Marzony ET; Sahebkar A
Skinmed; 2015; 13(1):15-21. PubMed ID: 25842469
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
Tanglertsampan C
J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
[TBL] [Abstract][Full Text] [Related]
37. Microneedling in androgenetic alopecia; comparing two different depths of microneedles.
Faghihi G; Nabavinejad S; Mokhtari F; Fatemi Naeini F; Iraji F
J Cosmet Dermatol; 2021 Apr; 20(4):1241-1247. PubMed ID: 32897622
[TBL] [Abstract][Full Text] [Related]
38. The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta-analysis.
Zhou Y; Chen C; Qu Q; Zhang C; Wang J; Fan Z; Miao Y; Hu Z
Dermatol Ther; 2020 Jul; 33(4):e13741. PubMed ID: 32478968
[TBL] [Abstract][Full Text] [Related]
39. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Vañó-Galván S; Pirmez R; Hermosa-Gelbard A; Moreno-Arrones ÓM; Saceda-Corralo D; Rodrigues-Barata R; Jimenez-Cauhe J; Koh WL; Poa JE; Jerjen R; Trindade de Carvalho L; John JM; Salas-Callo CI; Vincenzi C; Yin L; Lo-Sicco K; Waskiel-Burnat A; Starace M; Zamorano JL; Jaén-Olasolo P; Piraccini BM; Rudnicka L; Shapiro J; Tosti A; Sinclair R; Bhoyrul B
J Am Acad Dermatol; 2021 Jun; 84(6):1644-1651. PubMed ID: 33639244
[TBL] [Abstract][Full Text] [Related]
40. Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia.
Bao L; Gong L; Guo M; Liu T; Shi A; Zong H; Xu X; Chen H; Gao X; Li Y
J Cosmet Laser Ther; 2020; 22(1):1-7. PubMed ID: 29028377
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
